Takeda Takes Stake, Inks Deal With Newly Launched Izana Bioscience Post author:Sam Post published:December 13, 2017 Post category:BioPharma As part of the licence agreement, Takeda has taken a strategic equity stake in Izana. Source: BioSpace You Might Also Like Innoviva Files Preliminary Proxy Materials For 2017 Annual Meeting March 6, 2017 Novartis Showcases 4 Potential Blockbusters in Its Late-Stage Pipeline November 13, 2017 Celgene Crashed After Follicular Lymphoma Regimen Failed Phase III December 21, 2017
